4/30/24 - Elevated Tryptase - Now What?

PRESENTATION OBJECTIVES:
1. Describe the differences between mastocytosis and hereditary alpha-tryptasemia
2. Use tryptase calculations in the evaluation of mast cell activation
3. Describe the evidence based approach to mast cell activation syndrome management
DISCLOSURES:
Speaker:
• Regeneron/Sanofi
• AstraZeneca
• Amgen
• Optinose
• GSK
• Blueprint
• Genentech
Advisory Board Member:
• Optinose